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Abstract
Objective: The aim of this study was to evaluate whether overweight and obesity are associated with arterial
abnormalities in postmenopausal women and the contribution of the metabolic syndrome.
Methods: A total of 390 postmenopausal women (mean age, 63.1 T 7.7 y) living in the metropolitan area of
Naples, Southern Italy, and participating in a population-based cohort study (Progetto Atena) were offered an
ultrasound examination of the carotid arteries; 370 women accepted. Blood pressure, serum high-density lipoprotein
cholesterol, low-density lipoprotein cholesterol, triglycerides, fasting glucose, insulin, apolipoprotein B, and high-
sensitivity C-reactive protein were measured in all participants.
Results: Women in the second and third tertiles of body mass index showed a greater common carotid intima-
media thickness compared with those in the first tertile (tertile II vs I, odds ratio, 2.15; P = 0.013; tertile III vs I, odds
ratio, 2.24; P = 0.018), adjusted for age and metabolic syndrome. Obese and overweight postmenopausal women
showed greater common carotid lumen diameters as compared with lean postmenopausal women (mean T SD, 6.36 T
0.86, 6.16 T 0.65, and 5.96 T 0.59 mm, respectively; P G 0.001 [obese vs lean] and P = 0.04 [overweight vs lean]); no
statistical difference in carotid lumen diameter was found between obese and overweight postmenopausal women.
The statistical significance between obese and lean postmenopausal women was retained even after adding the
components of the metabolic syndrome as covariates.
Conclusions: These findings indicate an association between overweight, obesity, and preclinical carotid artery
abnormalities, independently of the metabolic syndrome, in a population of postmenopausal women.
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T
he prevalence of overweight and obesity is sharply
growing in the general population and has received in-
creasing attention in the past few years. Obesity is
associated with a high risk of developing coronary heart dis-
ease, stroke, hypertension, type 2 diabetes, and dyslipidemia.1<3
An increased cardiovascular risk characterizes postmeno-
pausal women.4 Elevated oxidized low-density lipoprotein (LDL)
plasma levels were found in postmenopausal women in com-
parison with fertile women.5 In postmenopausal women, lipid
and lipoprotein metabolism is markedly altered, as are fat mass
and visceral adiposity.6,7
Over the last decade, high-resolution B-mode ultrasound has
been used for the noninvasive assessment of carotid intima-
media thickness (IMT), a marker of early atherosclerosis.8<11
Cardiovascular risk factors relate positively to IMT of the
common carotid arteries, whereas in population-based samples,
the association with carotid lumen diameters is more complex,
and in some cases, adverse levels of risk factors may be asso-
ciated with larger lumens.12
In the present analysis, we evaluated whether overweight
and obesity were associated with carotid abnormalities in a
sample of postmenopausal women participating in a large, on-
going, prospective study (Progetto Atena).13 Furthermore, we
analyzed the contribution of the metabolic syndrome to arterial
abnormalities. Our study was performed in a geographical area
(southern Italy) where changes in dietary pattern (increasing
calorie and animal fat intake), together with sedentary habits,
have led to a high prevalence of overweight and obesity.14
METHODS
Study population
The main purpose of the Progetto Atena study was to inves-
tigate the causes of the chronic diseases that have a major impact
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on the female population. The study population was recruited
over a 6-month period by inviting the older three participants
from those referred daily to the Progetto Atena to undergo an
ultrasound examination of the carotid arteries, given their poten-
tially higher risk of atherosclerotic cardiovascular disease. The
same women (n = 400) were recalled after a period of 10 years
of follow-up (final visit). Of these, 390 agreed to participate
in the biochemical assay and clinical visit and 370 agreed to
undergo a second ultrasound examination. At the final visit, all
women were postmenopausal. The data from the second ultra-
sound examination were the object of the present study.
All women signed a written informed consent form, and
the study was approved by the ethics committees of the insti-
tutions involved.
Clinical and biochemical assessment
Anthropometric measurements were made with the partic-
ipant wearing indoor clothing and without shoes. Body mass
index (BMI), used as a measure of general obesity, was calcu-
lated as weight (kilograms) divided by height (meters squared).
Waist circumference, an index of abdominal obesity, was mea-
sured midway between the bottom of the rib cage and the top
of the iliac crest. BMI changes over the adult lifetime ($ BMI)
were calculated in comparison with BMI reported at 20 years
of age using the following formula: $ BMI = BMI at the final
visit j BMI at 20 years of age. Weight and height at 20 years
of age were assessed on the basis of a questionnaire.5 BMI
changes between the baseline and the final visit, during the
10-year observation period, were calculated using the fol-
lowing formula: $ BMI final versus baseline visit = BMI at
final visit j BMI at baseline visit.
Sitting brachial blood pressure was measured two times
using a random-zero sphygmomanometer, with a rest period of
5 or more minutes in between measurements. A standard ques-
tionnaire was used to collect information on smoking habits.
Blood specimens were collected after a 12- to 14-hour fast,
from 8:00 to 9:30 AM, to reduce the influence of circadian
variation. Total cholesterol and triglyceride concentrations were
measured using standard enzymatic methods.15,16 High-density
lipoprotein (HDL) cholesterol was measured after the pre-
cipitation of very-low-density lipoproteins and LDLs with
phosphotungstic acid,17 and LDL-cholesterol was calculated
according to the Friedewald formula. Fasting glucose levels were
enzymatically determined by the peroxidase method. Fast-
ing insulin levels were determined by enzyme immunoassay
(Ultrasensitive Insulin Elisa, Mercodia, Sweden). The error of
the method was evaluated on the two serum specimens at
small and large contents of insulin and was less than 10%.
Apolipoprotein B and high-sensitivity C-reactive protein were
measured with a turbidimetric assay using an automated method
(Cobas-Mira, Roche, Italy). The error of the method was eval-
uated by analyzing a plasma pool on a daily basis and was less
than 5%.The homeostasis model assessment index was used
to estimate insulin resistance and was calculated as fasting
serum insulin (KU/mL) fasting serum glucose (mM)/22.5, as
described by Matthews et al.18
The American Heart Association Scientific Statement cri-
teria19 were used to classify women as having the metabolic
syndrome on the basis of the presence of three or more of
the following risk factors: (1) waist circumference greater than
88 cm, (2) fasting triglyceride level of 150 mg/dL or greater,
(3) HDL-cholesterol level less than 50 mg/dL, (4) hypertension
(systolic blood pressure Q130 mm Hg, diastolic blood pres-
sure Q85 mm Hg), and (5) fasting glucose level of 100 mg/dL
or greater.
High-resolution carotid ultrasound
Carotid B-mode ultrasound examinations were performed
by a certified sonographer using an ESAOTE AU4 instrument.
The study protocol involved scanning the distal 1.0 cm of the
near and far walls of the common carotid arteries. The crest
at the origin of the bifurcation was used as an anatomical
landmark to identify this segment. In each examination, the
sonographer used different scanning angles (anterior, lateral,
and posterior) to identify the greatest IMT in each wall. Scans
were recorded on super 0.5-in VHS videotape for offline
analysis. Readers selected the frame that contained the thick-
est IMT for each of the four carotid walls. The mean of the
four maximum thicknesses (mean maximum) was used as the
ultrasound endpoint of the study. It was possible to obtain
common carotid IMT measurements in 361 of 370 women.
The coefficient of reliability for the common carotid IMT was
0.85. This figure includes instrument, subject, sonographer,
and reader variabilities. An additional 2 minutes of ultrasound
scanning of the common carotid artery was recorded at the end
of the protocol, paying attention to a perfect alignment of the
walls, to allow measurement of carotid diameters. The dis-
tance between the leading edge of the echo produced by the
intima-lumen interface of the near wall and the leading edge of
the echo produced by the intima-lumen interface of the far
wall was the lumen diameter. It was possible to obtain common
carotid lumen diameters in 354 of 370 participants.
Statistical analyses
Statistical analyses were performed using SPSS version 17.0
(SPSS, Inc., Chicago, IL). Continuous variables were described
as mean and SD; the analysis of covariance was used to obtain
age-adjusted means of physical and biochemical variables.
Variables that were not normally distributed (homeostasis
model assessment, triglycerides, and high-sensitivity C-reactive
protein) were logarithmically transformed before analyses.
Univariate logistic regression analyses were used to identify
predictors of an increased common carotid IMT (91 mm)20 or
increased lumen diameter (above 90th percentile lumen diam-
eter level). All variables that were significant at the univariate
analysis were subsequently included in a multivariate model
of logistic regression that excluded variables susceptible to
collinearity (ie, we introduced LDL tertiles and excluded apo-
lipoprotein B tertiles; similarly, we introduced BMI tertiles but
not waist circumference tertiles). Backward stepwise logistic
regression analyses were used to test the strength of associa-
tion between tertiles of the single components of the metabolic
syndrome and increased IMT.
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A general linear model was developed to test the associa-
tion of lumen diameter (dependent continuous variable) with
tertiles of BMI (fixed variable) after adjustment for age. After
this analysis, we added to this statistical model the single
components of the metabolic syndrome as covariates.
RESULTS
The physical and biochemical characteristics of the study
participants are shown in Table 1. In our cohort, there was a
high prevalence of overweight and obesity: the second tertile
of BMI was in the World Health Organization range of over-
weight (25.5-29.1 kg/m2) and the third tertile was in the range
of obesity (29.1-41.7 kg/m2). The prevalence of overweight/
obesity, following the World Health Organization classifica-
tion, was 71%. Of the 390 participants included in the present
study, 157 (40%) had the metabolic syndrome.
A gradual and significant increase in common carotid mean
maximum IMT was present across BMI tertiles (P = 0.013 for
linear trend), from lean (mean T SD, 1.00 T 0.19 mm) to over-
weight (1.04 T 0.19 mm) to obese (1.07 T 0.23 mm) women,
after adjustment for age.
In univariate logistic regression analysis, an increased com-
mon carotid IMT was related to tertiles of LDL-cholesterol and
apolipoprotein B concentrations, systolic blood pressure, BMI,
waist circumference, presence of metabolic syndrome, and
increased age. Similarly, increased lumen diameters were re-
lated to triglycerides, systolic blood pressure, diastolic blood
pressure, BMI, waist circumference, metabolic syndrome, and
age (Table 2).
In a multivariate model of logistic regression between in-
creased common carotid IMT or increased lumen diameter
and BMI tertiles, after controlling for age and metabolic syn-
drome diagnosis, women in the second and third tertile of
BMI showed an increased common carotid IMT compared
with those in the first tertile: tertile II versus I (odds ratio [OR],
2.15; 95% CI, 1.17-3.94; P = 0.013) and tertile III versus I
(OR, 2.24; 95% CI, 1.15-4.37; P = 0.018). Similarly, after
controlling for age and metabolic syndrome diagnosis, women
in the third tertile of BMI showed an increased lumen diam-
eter compared with those in the first tertile: tertile III versus I
(OR, 3.61; 95% CI, 1.14-11.40; P = 0.029; Table 3).
In a backward conditional stepwise logistic regression anal-
ysis that included the variables that were statistically significant
at univariate analyses, age, systolic blood pressure tertiles, and
BMI tertiles remained significantly associated with increased
IMT, whereas the association with LDL-cholesterol tertiles was
no longer statistically significant (Table 4).
A significant association was present between common ca-
rotid lumen diameters (considered as a continuous variable) and
BMI tertiles. Obese and overweight postmenopausal women
showed increased lumen diameters as compared with lean
postmenopausal women (6.36 T 0.86, 6.16 T 0.65, and 5.96 T
0.59 mm, respectively; P G 0.001 [obese vs lean] and 0.04
[overweight vs lean]; Fig. 1); no statistical difference was found
between obese and overweight postmenopausal women. In a
multivariate analysis, the statistical significance between obese
and lean postmenopausal women was retained even after add-
ing as covariates all the components of the metabolic syn-
drome, whereas between overweight and lean postmenopausal
women, it was reduced to a level that did not formally attain
TABLE 2. Univariate predictors of an increased common carotid
mean maximum IMT (91 mm; n = 202/361) and increased
lumen diameter (upper 90th percentile; n = 36/354)
Independent variables
Increased common
carotid IMT
Increased
lumen diameter
OR 95% CI OR 95% CI
Triglycerides tertilesa 1.24 0.93-1.64 1.62 1.08-2.42
Low-density lipoprotein
cholesterol tertilesa
1.37 1.05-1.78 0.89 0.58-1.37
High-density lipoprotein
cholesterol tertilesa
0.80 0.62-1.04 0.77 0.50-1.19
Apolipoprotein B tertilesa 1.33 1.02-1.73 1.14 0.74-1.75
High-sensitivity CRP tertilesa 0.97 0.75-1.25 1.49 0.97-2.29
HOMA tertilesa 1.27 0.98-1.65 1.11 0.72-1.72
Systolic blood pressure tertilesa 2.42 1.82-3.23 2.24 1.35-3.72
Diastolic blood pressure tertilesa 1.18 0.90-1.54 2.10 1.28-3.43
BMI tertilesa 1.50 1.15-1.96 1.98 1.21-3.21
Waist circumference tertilesa 1.40 1.08-1.81 1.88 1.18-2.99
$ BMI as compared
with age 20 ya
0.98 0.93-1.03 0.93 0.86-1.01
$ BMI final vs baseline visita 0.99 0.89-1.10 0.96 0.81-1.15
Metabolic syndrome diagnosisb 2.02 1.30-3.13 2.26 1.11-4.62
Agec 1.11 1.07-1.14 1.06 1.01-1.11
BMI changes over the adult lifetime ($BMI as compared with age 20 y)
was calculated in comparison with BMI reported at 20 y of age using the
following formula: $BMI = BMI at the final visitj BMI at 20 y of age. BMI
changes between baseline visit and the final visit, during the observation
period of 10 y, was calculated with the following formula: $ BMI final vs
baseline visit = BMI at final visit j BMI at baseline visit.
IMT, intima-media thickness; OR, odds ratio; CRP, C-reactive protein;
HOMA, homeostasis model assessment; BMI, body mass index.
aDiscrete variables (tertile 3 vs tertile 1).
bYes/no.
cContinuous variable.
TABLE 1. Clinical and biochemical characteristics
of the study population (N = 390)
Variable
Age, y 63.1 T 7.7
Total cholesterol, mg/dL 225.7 T 40
Triglycerides, mg/dL 115.9 T 55.6
High-density lipoprotein cholesterol, mg/dL 56.8 T 13.1
Low-density lipoprotein cholesterol, mg/dL 145.6 T 35.7
Fasting glucose, mg/dL 102.6 T 21.5
Apolipoprotein B, g/L 1.12 T 0.2
High-sensitivity CRP, mg/L 2.6 T 3.8
Insulin, mU/L 6.8 T 4.4
Body mass index, kg/m2 28.0 T 4.6
Waist circumference, cm 90.3 T 11.0
HOMA 1.7 T 1.34
Systolic blood pressure, mm Hg 140.1 T 19.5
Diastolic blood pressure, mm Hg 80.7 T 8.8
Values are expressed as mean T SD. International System conversion factors:
to convert triglycerides to millimoles per liter, multiply by 0.0113; to convert
high-density lipoprotein cholesterol to millimoles per liter, multiply by
0.02586; to convert glucose to millimoles per liter, multiply by 0.05551; to
convert total and low-density lipoprotein cholesterol to millimoles per liter,
multiply by 0.02586.
CRP, C-reactive protein; HOMA, homeostasis model assessment.
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statistical significance when systolic blood pressure, triglycer-
ides, or HDL-cholesterol was added to the statistical model.
DISCUSSION
The main finding of the present study is that postmen-
opausal women with high BMI showed increased common
carotid IMT and lumen diameters. This association persisted
after adjustment for the presence of the metabolic syndrome.
In a previous study, we demonstrated an association of obes-
ity and central fat distribution with carotid artery wall thick-
ening in middle-aged women.21 However, the population in
that study was almost 10 years younger, and almost half the
participants were in the premenopause or perimenopause age.
The relationship between BMI, metabolic syndrome, and
markers of atherosclerosis is controversial in women. In the
Women’s Ischemia Syndrome Evaluation study, the metabolic
syndrome and BMI were strongly associated, but only the former
was associated with a significantly increased 3-year risk of
death or major adverse cardiovascular event.22 In a sample of
313 postmenopausal women, the metabolic syndrome, but not
BMI, conferred an approximate threefold adjusted odds of ca-
rotid atherosclerosis.23 Yu et al24 found that abdominal obesity
and metabolic syndrome were both associated with carotid IMT,
independently of general obesity, in asymptomatic Chinese
postmenopausal women. In a recent analysis conducted in 74
postmenopausal women, multivariate analyses demonstrated
that menopause and body weight were predictors of common
carotid diameter, independently of atherosclerotic risk factors
and metabolic variables.25 Our study is not in line with another
recent observation that brachial artery but not common carotid
artery diameter correlated with obesity and waist circumfer-
ence, independently of systolic blood pressure and other risk
factors in postmenopausal women.26
Compensatory arterial enlargement is considered a common
pathobiological response in early atherosclerosis.27 In the present
research, which is focused on postmenopausal Mediterranean
women, obesity per se promoted carotid enlargement, whereas
overweight needed the contribution of other cardiovascular risk
factors (ie, blood pressure and/or HDL-cholesterol and/or tri-
glycerides) to allow the adaptive remodeling of the carotid
wall. We cannot exclude the possibility that, at least to a large
extent, the association between BMI and carotid diameters
in postmenopausal women could depend on body composition
(particularly fat-free mass) that may modulate carotid luminal
diameter through changes in stroke volume, as suggested by
other authors.28
CONCLUSIONS
Our knowledge of the pathophysiology of cardiovascu-
lar disease comes mainly from studies in men, and therefore,
more sex-specific data are required.29 Subclinical atherosclerotic
TABLE 4. Relationships between increased common carotid
mean maximum IMT, SBP tertiles, BMI tertiles, and
LDL-cholesterol tertiles
Independent variables
Dependent variable: increased
mean maximum IMTa
OR 95% CI
Model 1
Ageb 1.1 1.06-1.14
SBP tertilesc 1.77 1.31-2.40
BMI tertilesc 1.16 1.07-1.94
LDL tertilesc 1.44 0.87-1.56
Model 2
Ageb 1.1 1.06-1.14
SBP tertilesc 1.79 1.32-2.42
BMI tertilesc 1.45 1.08-1.95
Backward stepwise multivariate logistic analyses.
Model 1: all variables statistically significant in univariate analyses.
Model 2: all variables statistically significant in univariate analyses, except
LDL tertiles.
IMT, intima-media thickness; SBP, systolic blood pressure; BMI, body mass
index; LDL, low-density lipoprotein; OR, odds ratio.
aDichotomous variable: increased IMT greater than 1 mm.
bContinuous variable.
cDiscrete variables (tertile 3 vs tertile 1).
FIG. 1. Lumen diameter by BMI values (N = 390). Error bars indicate
SE. BMI, body mass index.
TABLE 3. Relationships among increased common carotid mean
maximum IMT, BMI tertiles, and metabolic syndrome diagnosis
and among increased common carotid lumen diameter,
BMI tertiles, and metabolic syndrome diagnosis
Dependent variable: increased mean maximum IMTa
Independent variables P OR 95% CI for OR
BMI tertile I Reference 1
BMI tertile II 0.013 2.15 1.17-3.22
BMI tertile III 0.018 2.24 1.15-4.37
Ageb G0.001 1.11 1.08-1.15
Metabolic syndrome diagnosisc 0.399 1.26 0.73-2.20
Dependent variable: lumen diametera
Independent variables P OR 95% CI for OR
BMI tertile I Reference 1
BMI tertile II 0.271 1.93 0.59-6.23
BMI tertile III 0.029 3.61 1.14-11.40
Ageb 0.007 1.07 1.02-1.13
Metabolic syndrome diagnosisc 0.448 1.38 0.60-3.17
Multivariate logistic analyses.
IMT, intima-media thickness; BMI, body mass index; OR, odds ratio.
aDichotomous variable: increased IMT greater than 1 mm; increased lumen
diameter above the 90th percentile.
bContinuous variable.
cYes/no.
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changes in response to age and other hypertrophic stimuli may
be different between women and men.30 Furthermore, de-
spite the fact that after menopause, women are more likely to
experience cardiovascular disease than men are, physicians
often underdiagnose and undertreat such women.31 In this
context (postmenopausal women), our research demonstrated
an independent role of obesity in determining subclinical
atherosclerosis.
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